Literature DB >> 3774022

Pharmacodynamics and pharmacokinetics of furosemide combinations with potassium-retaining and thiazide-like diuretics: clearance and micropuncture studies.

M Hropot, F Sörgel, E Mutschler.   

Abstract

The interaction between furosemide on the one hand and hydrochlorothiazide, tizolemide, amiloride and triamterene on the other was studied by clearance and micropuncture techniques in rats. Simultaneous administration of furosemide with hydrochlorothiazide and tizolemide distinctly increased the natriuresis compared to that induced by furosemide alone, whereas the potassium excretion diminished. In contrast, amiloride and triamterene primarily decreased furosemide-induced fractional potassium excretion by about 30%, whereas sodium excretion increased only slightly compared to that produced by furosemide alone. Hydrochlorothiazide and triamterene significantly decreased furosemide secretion and changed its pharmacokinetics. Furosemide plasma concentration increased, thus possibly prolonging the salidiuretic effect. Amiloride and tizolemide did not influence the secretion of furosemide at all.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3774022     DOI: 10.1007/bf00500025

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  18 in total

1.  Effect of amiloride, ouabain, and furosemide on distal tubular function in the rat.

Authors:  C G Duarte; F Chomety; G Giebisch
Journal:  Am J Physiol       Date:  1971-08

2.  Potassium-sparing effect of amiloride in a diuretic factorial study in man.

Authors:  G J Schapel; D G Edwards; J Robinson
Journal:  Clin Exp Pharmacol Physiol       Date:  1975 Jul-Aug       Impact factor: 2.557

3.  Effect of probenecid on excretion and natriuretic action of furosemide.

Authors:  F Andreasen; B Sigurd; E Steiness
Journal:  Eur J Clin Pharmacol       Date:  1980-11       Impact factor: 2.953

4.  Effects of probenecid on furosemide response.

Authors:  D C Brater
Journal:  Clin Pharmacol Ther       Date:  1978-11       Impact factor: 6.875

5.  Tubular action of diuretics: distal effects on electrolyte transport and acidification.

Authors:  M Hropot; N Fowler; B Karlmark; G Giebisch
Journal:  Kidney Int       Date:  1985-09       Impact factor: 10.612

6.  Effects of xipamide and triamterene - alone or in combination - on electrolyte excretion in the rat.

Authors:  M Hohenegger; F Holzer
Journal:  Int J Clin Pharmacol Biopharm       Date:  1976-06

7.  [On the diuretic and saluretic activity of p-hydroxytriamterene and methoxytriamterene (author's transl)].

Authors:  G Vollmer; E Mutschler; K D Völger
Journal:  Arzneimittelforschung       Date:  1981

8.  Effects of triamterene and its phase I and phase II metabolities on sodium transport of the isolated frog skin.

Authors:  H J Kramer; M Rörig; K D Völger
Journal:  Pharmacology       Date:  1981       Impact factor: 2.547

9.  [Furosemide and metolazone: a highly effective diuretic combination].

Authors:  J Furrer; O M Hess; U Kuhlmann; N Satz; W Siegenthaler
Journal:  Schweiz Med Wochenschr       Date:  1980-11-29

10.  The physiological disposition of chlorothiazide (diuril) in the dog.

Authors:  J E BAER; H L LEIDY; A V BROOKS; K H BEYER
Journal:  J Pharmacol Exp Ther       Date:  1959-04       Impact factor: 4.030

View more
  3 in total

Review 1.  Diuretic combinations in refractory oedema states: pharmacokinetic-pharmacodynamic relationships.

Authors:  D A Sica; T W Gehr
Journal:  Clin Pharmacokinet       Date:  1996-03       Impact factor: 6.447

2.  Furosemide responsiveness, non-adherence and resistance during the chronic treatment of heart failure: a longitudinal study.

Authors:  Robert J MacFadyen; J Christopher Gorski; D Craig Brater; Allan D Struthers
Journal:  Br J Clin Pharmacol       Date:  2004-05       Impact factor: 4.335

3.  Stability of furosemide and chlorothiazide stored in syringes.

Authors:  Jeffrey J Cies; Wayne S Moore; Arun Chopra; Guizhen Lu; Robert W Mason
Journal:  Am J Health Syst Pharm       Date:  2015-12-15       Impact factor: 2.637

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.